Teva Pharmaceuticals has recalled 9,452 cartons of Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), a medication used to treat certain stomach and esophageal problems. The recall was initiated because an unknown brown residue was found adhering to the inside of one vial during inspection. This contamination indicates a quality defect that could pose a health risk if the medication is administered. This product was distributed nationwide across the United States and Puerto Rico.
The presence of unknown chemical residue inside a sterile injectable vial could result in the administration of contaminated medication, potentially leading to adverse reactions, infections, or other localized or systemic health complications.
Pharmaceutical refund and guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.